Home/Filings/4/0001179110-15-009363
4//SEC Filing

ALDER BIOPHARMACEUTICALS INC 4

Accession 0001179110-15-009363

CIK 0001423824operating

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 6:08 PM ET

Size

28.8 KB

Accession

0001179110-15-009363

Insider Transaction Report

Form 4
Period: 2015-06-04
Transactions
  • Other

    Common Stock

    2015-06-04+3,6643,664 total
  • Other

    Common Stock

    2015-06-04+2,7822,782 total
  • Other

    Common Stock

    2015-06-04+2,3402,340 total
  • Other

    Common Stock

    2015-06-04+4,5474,547 total
  • Other

    Common Stock

    2015-06-04+1,3921,392 total
Holdings
  • Common Stock

    (indirect: See Footnote (10))
    2,024,483
Transactions
  • Other

    Common Stock

    2015-06-04+4,5474,547 total
  • Other

    Common Stock

    2015-06-04+2,7822,782 total
  • Other

    Common Stock

    2015-06-04+2,3402,340 total
  • Other

    Common Stock

    2015-06-04+1,3921,392 total
  • Other

    Common Stock

    2015-06-04+3,6643,664 total
Holdings
  • Common Stock

    (indirect: See Footnote (10))
    2,024,483
Transactions
  • Other

    Common Stock

    2015-06-04+3,6643,664 total
  • Other

    Common Stock

    2015-06-04+2,7822,782 total
  • Other

    Common Stock

    2015-06-04+4,5474,547 total
  • Other

    Common Stock

    2015-06-04+1,3921,392 total
  • Other

    Common Stock

    2015-06-04+2,3402,340 total
Holdings
  • Common Stock

    (indirect: See Footnote (10))
    2,024,483
Transactions
  • Other

    Common Stock

    2015-06-04+1,3921,392 total
  • Other

    Common Stock

    2015-06-04+3,6643,664 total
  • Other

    Common Stock

    2015-06-04+2,7822,782 total
  • Other

    Common Stock

    2015-06-04+2,3402,340 total
  • Other

    Common Stock

    2015-06-04+4,5474,547 total
Holdings
  • Common Stock

    (indirect: See Footnote (10))
    2,024,483
Transactions
  • Other

    Common Stock

    2015-06-04+2,3402,340 total
  • Other

    Common Stock

    2015-06-04+4,5474,547 total
  • Other

    Common Stock

    2015-06-04+1,3921,392 total
  • Other

    Common Stock

    2015-06-04+3,6643,664 total
  • Other

    Common Stock

    2015-06-04+2,7822,782 total
Holdings
  • Common Stock

    (indirect: See Footnote (10))
    2,024,483
Transactions
  • Other

    Common Stock

    2015-06-04+4,5474,547 total
  • Other

    Common Stock

    2015-06-04+1,3921,392 total
  • Other

    Common Stock

    2015-06-04+2,7822,782 total
  • Other

    Common Stock

    2015-06-04+3,6643,664 total
  • Other

    Common Stock

    2015-06-04+2,3402,340 total
Holdings
  • Common Stock

    (indirect: See Footnote (10))
    2,024,483
Transactions
  • Other

    Common Stock

    2015-06-04+4,5474,547 total
  • Other

    Common Stock

    2015-06-04+2,7822,782 total
  • Other

    Common Stock

    2015-06-04+2,3402,340 total
  • Other

    Common Stock

    2015-06-04+1,3921,392 total
  • Other

    Common Stock

    2015-06-04+3,6643,664 total
Holdings
  • Common Stock

    (indirect: See Footnote (10))
    2,024,483
Transactions
  • Other

    Common Stock

    2015-06-04+4,5474,547 total
  • Other

    Common Stock

    2015-06-04+3,6643,664 total
  • Other

    Common Stock

    2015-06-04+2,3402,340 total
  • Other

    Common Stock

    2015-06-04+1,3921,392 total
  • Other

    Common Stock

    2015-06-04+2,7822,782 total
Holdings
  • Common Stock

    (indirect: See Footnote (10))
    2,024,483
Footnotes (10)
  • [F1]Represents a pro rata in-kind distribution, without additional consideration, of 1,973,885 shares of Common Stock of the Issuer by Sevin Rosen Fund IX L.P. and 50,552 shares of Common Stock of the Issuer by Sevin Rosen IX Affiliates Fund L.P.
  • [F10]Total Common Shares of 2,024,483 represents 46 shares owned directly by SRB Associates IX L.P. ("SRBAIX"), 1,973,885 shares owned directly by Sevin Rosen Fund IX L.P. ("SRFIX") and 50,552 shares owned directly by Sevin Rosen IX Affiliates Fund L.P. ("SRIX AFF"). SRBAIX is the general partner of SRFIX and SRIX AFF, and in that capacity has shared voting and dispositive power over such shares. SRBAIX disclaims beneficial ownership of such shares except to the extent of its pecuniary interest. Jaggers, Bayless, Domenik, Kimzey, McLean, Oxaal, Schuele and Sturiale are members of the general partner of SRBAIX, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
  • [F2]Represents the receipt of shares by John V. Jaggers ("Jaggers") of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (1) above.
  • [F3]Represents the receipt of shares by Jon W. Bayless("Bayless") of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (1) above.
  • [F4]Represents the receipt of shares by Stephen L. Domenik ("Domenik") of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (1) above.
  • [F5]Represents the receipt of shares by Jackie R. Kimzey ("Kimzey") of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (1) above.
  • [F6]Represents the receipt of shares by David J. McLean ("McLean") of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (1) above.
  • [F7]Represents the receipt of shares by John T. Oxaal ("Oxaal") of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (1) above.
  • [F8]Represents the receipt of shares by Alan R. Schuele ("Schuele") of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (1) above.
  • [F9]Represents the receipt of shares by Nicholas G. Sturiale ("Sturiale") of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (1) above.

Issuer

ALDER BIOPHARMACEUTICALS INC

CIK 0001423824

Entity typeoperating

Related Parties

1
  • filerCIK 0001423824

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 6:08 PM ET
Size
28.8 KB